Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CISPLATIN Cause Intentional product use issue? 241 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 241 reports of Intentional product use issue have been filed in association with CISPLATIN (CISplatin). This represents 0.5% of all adverse event reports for CISPLATIN.

241
Reports of Intentional product use issue with CISPLATIN
0.5%
of all CISPLATIN reports
49
Deaths
68
Hospitalizations

How Dangerous Is Intentional product use issue From CISPLATIN?

Of the 241 reports, 49 (20.3%) resulted in death, 68 (28.2%) required hospitalization, and 7 (2.9%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CISPLATIN. However, 241 reports have been filed with the FAERS database.

What Other Side Effects Does CISPLATIN Cause?

Off label use (4,359) Disease progression (3,746) Neutropenia (3,095) Febrile neutropenia (3,010) Nausea (2,923) Drug ineffective (2,608) Thrombocytopenia (2,565) Anaemia (2,530) Vomiting (2,326) Diarrhoea (2,022)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which CISPLATIN Alternatives Have Lower Intentional product use issue Risk?

CISPLATIN vs CISPLATIN\CYTARABINE\DEXAMETHASONE CISPLATIN vs CITALOPRAM CISPLATIN vs CITALOPRAM HYDROBROMIDE CISPLATIN vs CITALOPRAM\CITALOPRAM HYDROBROMIDE CISPLATIN vs CITICOLINE

Related Pages

CISPLATIN Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue CISPLATIN Demographics